Concr

Solving data to enable precision therapy for all

Follow us on LinkedIn for the latest news:

[Concr @ConcrTweets]

As world’s cancer research community prepares to gather at the ASCO Annual Meeting, catch up with our recent studies presented earlier this year at AACR:

https://t.co/2qLPwBq8Xp

#precisiononcology
#MachineLearning
#techbio
#FromCosmologyToOncology

[Concr @ConcrTweets]

Listen to our CEO Matt Foster discuss origins of Concr and how we work with partners to improve drug development to realise the promise of #PrecisionOncology in this episode of AI for Pharma Growth:

https://t.co/hkMdoGrOxU

#AI #MachineLearning #TechBio #FromCosmologyToOncology

[Concr @ConcrTweets]

#LSXWorld Congress in only 2 days away!

You���re invited to our showcase on 3rd May at 14.30 at the newly-established techbio stage, to find out more about our current work and plans for the future.

https://t.co/z9OME1oAIt

#techbio #precisiononcology #fromcosmologytooncology

[Concr @ConcrTweets]

To access the story and learn more about VISION:
https://t.co/OkP72EfRWy

#SaMD
#Genomics
#ClinicalTrials
#BreastCancer
#PrecisionOncology
#FromCosmologyToOncology

[Concr @ConcrTweets]

Having an #NHS medical oncologist as a Co-Founder and CSO doesn’t just mean that our predictions are clinically meaningful; it also ensures that Concr technology addresses unmet clinical needs, to the highest standards.

[Concr @ConcrTweets]

It is designed to validate Concr modelling to predict drug responses and patient survival for women with early #TNBC by merging clinical information with genomic data, identifying which drugs will work and which won’t, before the patient has started treatment.

[Concr @ConcrTweets]

To read the article:
https://t.co/AHVad4mnXh

#TechBio
#Biomarkers
#CancerResearch
#PrecisionOncology
#FromCosmologyToOncology

[Concr @ConcrTweets]

Biomarkers hold the key to unlocking the links between intricate biological processes and clinical outcomes. For biomarkers to pave the way for reliable and accessible #PersonalisedMedicine, particularly in #cancer, they must be accurate, informative and cost-effective.

[Concr @ConcrTweets]

In this piece, they explore how #biomarkers have already revolutionised the current clinical landscape, and what more needs to be done, in order to match more #cancer patients with safer, more effective and affordable therapies.

[Concr @ConcrTweets]

For more information about the Concr presentation and posters:
https://t.co/MTNRly2OkB

#TechBio #Cancer
#MachineLearning
#TranslationalOncology
#FromCosmologyToOncology

[Concr @ConcrTweets]

If you're at #AACR23 today, then make sure to listen to Dr Aidan Kubeyev present on the results of the latest application of Concr’s prognostic #MachineLearning models on early #BreastCancer.

[Concr @ConcrTweets]

Join Dr Matthew Griffiths and Dr Uzma Asghar in the poster hall (Section 33, Board Numbers 7 and 12) from 1:30 PM to learn about how Concr technology can differentiate tumours from other cell types from H&E slides, and identify tissue of origin from somatic mutation features.

[Concr @ConcrTweets]

Find us at the TechBio Showcase on May 3rd at 2:30 PM or get in touch to book a 1:1 today!

To find out more about Concr at LSX World Congress 2023:
https://t.co/z9OME1p8y1

#TechBio
#LSXWorld
#PrecisionMedicine
#FromCosmologyToOncology

[Concr @ConcrTweets]

Concr will be attending the 9th #LSXWorld Congress in London next month.

Our Head of Strategy, Dr Irina Babina, will join the representatives of leading #biotech, #medtech and #healthtech companies to discuss the future of healthcare and life sciences innovation.

[Concr @ConcrTweets]

For more information about Concr at #AACR23: https://t.co/2HEKw8vS1B

#TechBio #Cancer
#MachineLearning
#TranslationalOncology
#FromCosmologyToOncology

[Concr @ConcrTweets]

Only three days left before #AACR23!

With two posters and an oral presentation, there will be much to talk about!

Come find us presenting on Tuesday 18th, or get in touch now to lock in a meeting with the Concr delegation:
https://t.co/JGt8AH3tn9

[Concr @ConcrTweets]

The same statistical methodologies are at the heart of Concr’s algorithms aimed at unearthing #biomarkers of response to cancer treatments.

To learn more about how Concr utilises this approach to make sense of disparate #oncology data:
https://t.co/AyCWCcgW3D

#TechBio

[Concr @ConcrTweets]

What do ultramassive #BlackHoles and #Cancer have in common?

They are “elusive, and their origins are unclear”.

Additionally, both are studied by our Durham University collaborator, @JwNightingale22, who applied a technique called #GravitationalLensing to the discovery.

[Durham University @durham_uni]

A team of #astronomers lead by @JwNightingale22 from @DurhamPhysics has discovered one of the biggest #blackholes ever found using light-bending gravity.

Find out more about this research, published today by @RoyalAstroSoc here 👉 https://t.co/2fe7Wdfetu
#DUresearch